家族史与肾细胞癌风险:一项全国多登记病例对照研究
该研究基于瑞典肾细胞癌数据库、多代登记和瑞典癌症登记,纳入2005至2014年诊断的9416例肾细胞癌患者及10倍匹配对照,分析家族史与肾细胞癌风险的关联。结果显示,有1个及以上一级亲属患肾细胞癌者风险约为无家族史者的2倍(OR 1.9;CI 1.65-2.16),女性OR 2.4(CI 1.93-2.92),男性OR 1.6(CI 1.35-1.93),2个及以上一级亲属者风险约为6倍(95% CI 2.37-15.5)。
要点
- 9416例肾细胞癌中294例(3.1%)有1个及以上一级亲属患肾细胞癌。
- 有1个及以上一级亲属患肾细胞癌者肾细胞癌风险约为无家族史者的2倍(OR 1.9;CI 1.65-2.16)。
- 有2个及以上一级亲属患肾细胞癌者风险约为6倍(95% CI 2.37-15.5),构成小的高危群体。
核心结论
- 在瑞典数据集中,3.1%的肾细胞癌患者有1个及以上一级亲属诊断为肾细胞癌。
- 散发性与家族性肾细胞癌的中位诊断年龄无统计学差异。
- 有1个及以上一级亲属患肾细胞癌使肾细胞癌风险约翻倍,女性风险增加高于男性。
- 有2个一级亲属患肾细胞癌者构成小的高危群体,可能从筛查中获益。
研究设计与样本
- 全国多登记病例对照研究,利用瑞典肾细胞癌数据库、多代登记和瑞典癌症登记识别2005至2014年诊断的肾细胞癌病例及10倍匹配对照。
- 共纳入9416例肾细胞癌病例。
- 分析家族史与肾细胞癌的关联,并按性别和年龄组分层。
主要发现
- 9416例肾细胞癌中294例(3.1%)有1个及以上父母或兄弟姐妹(一级亲属)患肾细胞癌。
- 有患病一级亲属的病例中位诊断年龄为65岁(IQR 59-71),所有病例为68岁(IQR 60-75)。
- 家族性肾细胞癌中女性比例显著高于散发性肾细胞癌(44.6% vs 38.5%,P = .035)。
- 有1个及以上一级亲属患肾细胞癌者肾细胞癌风险约为无家族史者的2倍(OR 1.9;CI 1.65-2.16)。
- 分层分析显示女性OR 2.4(CI 1.93-2.92),男性OR 1.6(CI 1.35-1.93)。
临床怎么用
- 作者认为有2个一级亲属患肾细胞癌者构成小的高危群体,可能从筛查中获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our purpose was to investigate the association between family history of renal cell carcinoma (RCC) and RCC risk. MATERIALS AND METHODS: RCC cases diagnosed in Sweden between 2005 and 2014 and 10 matched controls were identified using the Renal Cell Cancer Database Sweden, with linkage to the Multigeneration Register and the Swedish Cancer Registry. The association between a family history of RCC and RCC was investigated, overall and by sex and age groups. RESULTS: Among 9416 RCC cases, 294 (3.1%) had 1 or more parent or sibling (first-degree relative [FDR]) with RCC. Median age at diagnosis for cases with an affected FDR was 65 years (IQR 59-71) and 68 years (IQR 60-75) for all cases. The proportion of women was significantly higher among familial RCC compared to sporadic RCC (44.6% vs 38.5%, P = .035). RCC was twice as likely with 1 or more FDR with RCC (OR 1.9; CI 1.65-2.16). Stratified analysis showed an OR of 2.4 for women (CI 1.93-2.92) and 1.6 for men (CI 1.35-1.93). Two or more FDRs was associated with a sixfold increased risk (95% CI 2.37-15.5). Familial RCC was strongly associated with bilateral and multifocal tumors (OR 5.5; CI 2.36-13.0, OR 3.5; CI 1.89-6.49). CONCLUSIONS: In this Swedish data set, 3.1% of RCC patients have 1 or more FDR diagnosed with RCC. There was no statistical difference in median age between sporadic RCC and familial RCC. Having 1 or more FDR with RCC approximately doubles the risk of RCC with a higher risk increase for women than for men. People with 2 FDRs with RCC constitute a small high-risk group that may benefit from screening.
引用
- Jakobsson RG, Nasic S, Bratt O, et al. Family History and Risk of Renal Cell Carcinoma: A National Multiregister Case-Control Study. J Urol. 2023. PMID: 37862613. doi:10.1097/JU.0000000000003765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。